m+Medelevator.RU
← Поиск публикаций
Cureus · 2025

Toxic Epidermal Necrolysis: A Rare Complication of Allopurinol.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Barreto Francisco, Jardim Margarida, Graça Carina, Catanho Tiago, Nóbrega José J

Аннотация

Toxic epidermal necrolysis (TEN) is a rare, life-threatening, mucocutaneous disorder characterized by extensive epidermal detachment and necrosis, often triggered by medications. Prompt recognition and management are critical to improving outcomes. The present article reports a case of an 80-year-old patient, with a history of gout and essential hypertension, who presented to the emergency department with pyrexia and a generalized macular rash characterized by dark centers and vesicles, accompanied by severe pruritus. The patient had recommenced allopurinol therapy one week prior, following an acute gout episode. Clinical examination revealed an extensively distributed, highly painful dark macular rash with cutaneous desquamation and a positive Nikolsky's sign, vesiculation, plasmorrhexis, and mucositis. Laboratory findings indicated elevated inflammatory markers. The patient was placed in isolation due to suspected TEN and managed with paraffin gauze dressings, temperature regulation, and fluid resuscitation. The condition was further complicated by refractory septic shock secondary to nosocomial pneumonia, ultimately resulting in the patient's demise. This case underscores the importance of early recognition, discontinuation of the causative agent, and comprehensive supportive care in the management of TEN. The case highlights the need for a multidisciplinary approach and the role of adjunctive therapies in improving outcomes. Further studies are warranted to optimize treatment protocols for this devastating condition.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты